Neurocrine Biosciences | NBIX - EPS Earnings Per Share


Neurocrine Biosciences reported $1.88 in EPS Earnings Per Share for its fiscal quarter ending in December of 2025.


Fiscal Calendar Actual Consensus Previous Date
FY2025Q4 Dec/2025 1.88 1.86 1.69 Feb/11 2026
FY2025Q3 Sep/2025 2.17 1.56 1.81 Oct/28 2025
FY2025Q2 Jun/2025 1.65 0.98 1.63 Jul/30 2025
FY2025Q1 Mar/2025 0.70 0.86 1.20 May/05 2025
FY2024Q4 Dec/2024 1.69 1.57 1.54 Feb/06 2025




Eps Change Date
AbbVie USD 2.71 0.85 Dec/2025
Acadia Pharmaceuticals USD 0.42 0.26 Sep/2025
Agios Pharmaceuticals USD -1.86 0.08 Dec/2025
ALKERMES USD 0.49 0.03 Sep/2025
Alnylam Pharmaceuticals USD 1.25 1.65 Dec/2025
Amgen USD 5.29 0.35 Dec/2025
Biogen USD 1.99 2.82 Dec/2025
BioMarin Pharmaceutical USD 0.46 0.34 Dec/2025
Cytokinetics USD -1.5 1.05 Dec/2025
Enanta Pharmaceuticals USD -1.05 0.31 Dec/2024
Exelixis USD 0.97 0.19 Dec/2025
Gilead Sciences USD 1.86 0.61 Dec/2025
Halozyme Therapeutics USD -0.24 1.96 Dec/2025
Incyte USD 1.8 0.46 Dec/2025
Ionis Pharmaceuticals USD -0.8 1.5 Sep/2025
Nektar Therapeutics USD -0.18 0.07 Sep/2024
Neurocrine Biosciences USD 1.88 0.29 Dec/2025
Pfizer USD 0.66 0.21 Dec/2025
Prothena USD -0.68 1.66 Sep/2025
Regeneron Pharmaceuticals USD 11.44 0.39 Dec/2025
Repligen USD 0.49 0.03 Dec/2025
Rigel Pharmaceuticals USD 0.7 0.76 Sep/2024
Sarepta Therapeutics USD -0.13 2.15 Sep/2025
Teva Pharmaceutical Industries USD 2.98 0.43 Dec/2025
Ultragenyx Pharmaceutical USD -1.29 0.52 Dec/2025
Vertex Pharmaceuticals USD 5.03 0.23 Dec/2025
Xoma USD -1.59 2.43 Sep/2024